536 related articles for article (PubMed ID: 12396002)
1. C1q, autoimmunity and apoptosis.
Botto M; Walport MJ
Immunobiology; 2002 Sep; 205(4-5):395-406. PubMed ID: 12396002
[TBL] [Abstract][Full Text] [Related]
2. C1q and systemic lupus erythematosus.
Walport MJ; Davies KA; Botto M
Immunobiology; 1998 Aug; 199(2):265-85. PubMed ID: 9777411
[TBL] [Abstract][Full Text] [Related]
3. Complement deficiencies in humans and animals: links to autoimmunity.
Lewis MJ; Botto M
Autoimmunity; 2006 Aug; 39(5):367-78. PubMed ID: 16923536
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus and complement deficiency: clues to a novel role for the classical complement pathway in the maintenance of immune tolerance.
Navratil JS; Korb LC; Ahearn JM
Immunopharmacology; 1999 May; 42(1-3):47-52. PubMed ID: 10408365
[TBL] [Abstract][Full Text] [Related]
5. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
Potlukova E; Kralikova P
Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
[TBL] [Abstract][Full Text] [Related]
6. Complement and systemic lupus erythematosus.
Walport MJ
Arthritis Res; 2002; 4 Suppl 3(Suppl 3):S279-93. PubMed ID: 12110148
[TBL] [Abstract][Full Text] [Related]
7. Hereditary C1q deficiency and systemic lupus erythematosus.
Bowness P; Davies KA; Norsworthy PJ; Athanassiou P; Taylor-Wiedeman J; Borysiewicz LK; Meyer PA; Walport MJ
QJM; 1994 Aug; 87(8):455-64. PubMed ID: 7922299
[TBL] [Abstract][Full Text] [Related]
8. Complement deficiencies and systemic lupus erythematosus.
Truedsson L; Bengtsson AA; Sturfelt G
Autoimmunity; 2007 Dec; 40(8):560-6. PubMed ID: 18075790
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
[TBL] [Abstract][Full Text] [Related]
10. [Apoptosis and C1q: possible explanations for the pathogenesis of systemic lupus erythematosus].
Trendelenburg M; Schifferli JA
Z Rheumatol; 2000 Jun; 59(3):172-5. PubMed ID: 10929445
[TBL] [Abstract][Full Text] [Related]
11. Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus.
Holers VM
J Clin Invest; 2004 Sep; 114(5):616-9. PubMed ID: 15343378
[TBL] [Abstract][Full Text] [Related]
12. C1q knock-out mice for the study of complement deficiency in autoimmune disease.
Botto M
Exp Clin Immunogenet; 1998; 15(4):231-4. PubMed ID: 10072632
[TBL] [Abstract][Full Text] [Related]
13. Functional complement C1q abnormality leads to impaired immune complexes and apoptotic cell clearance.
Roumenina LT; Sène D; Radanova M; Blouin J; Halbwachs-Mecarelli L; Dragon-Durey MA; Fridman WH; Fremeaux-Bacchi V
J Immunol; 2011 Oct; 187(8):4369-73. PubMed ID: 21930969
[TBL] [Abstract][Full Text] [Related]
14. Anti C1q antibodies in cutaneous lupus erythematosus.
Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
[TBL] [Abstract][Full Text] [Related]
15. Clearance of dying cells and systemic lupus erythematosus: the role of C1q and the complement system.
Mevorach D
Apoptosis; 2010 Sep; 15(9):1114-23. PubMed ID: 20683667
[TBL] [Abstract][Full Text] [Related]
16. C1q restrains autoimmunity and viral infection by regulating CD8
Ling GS; Crawford G; Buang N; Bartok I; Tian K; Thielens NM; Bally I; Harker JA; Ashton-Rickardt PG; Rutschmann S; Strid J; Botto M
Science; 2018 May; 360(6388):558-563. PubMed ID: 29724957
[TBL] [Abstract][Full Text] [Related]
17. Links between complement deficiency and apoptosis.
Botto M
Arthritis Res; 2001; 3(4):207-10. PubMed ID: 11438036
[TBL] [Abstract][Full Text] [Related]
18. Direct binding of C1q to apoptotic cells and cell blebs induces complement activation.
Nauta AJ; Trouw LA; Daha MR; Tijsma O; Nieuwland R; Schwaeble WJ; Gingras AR; Mantovani A; Hack EC; Roos A
Eur J Immunol; 2002 Jun; 32(6):1726-36. PubMed ID: 12115656
[TBL] [Abstract][Full Text] [Related]
19. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
Pang Y; Yang XW; Song Y; Yu F; Zhao MH
Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
[TBL] [Abstract][Full Text] [Related]
20. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited.
Korb LC; Ahearn JM
J Immunol; 1997 May; 158(10):4525-8. PubMed ID: 9144462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
